A Single-centre Study of Entonox Versus Midazolam Sedation in Gastroscopy
Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This study aims to determine whether Entonox (gas and air) is at least as good as intravenous
midazolam in providing analgesia and sedation during gastroscopy. Entonox is used as an
adjunct in lower gastrointestinal procedures but is not routinely used in gastroscopy, and
there is only one similar published study to date, which was performed in children. The main
advantage of Entonox over midazolam is the quick recovery time following withdrawal of the
agent, which enables patients to return to independent normal life. The investigators would
like to be able to offer Entonox to patients as an option for sedation during gastroscopy,
this study is being conducted to determine if it is a safe and feasible option.